Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.452 GBX | -4.13% | -8.93% | -36.85% |
Apr. 25 | Hemogenyx Pharmaceuticals Plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 29 | Hemogenyx Pharmaceuticals raises money for leukaemia treatment | AN |
Business Summary
Number of employees: 14
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alexis Sandler
FOU | Founder | - | 11-12-31 |
Founder | 59 | 11-12-31 | |
Elina Shrestha
CTO | Chief Tech/Sci/R&D Officer | - | - |
Stuart Tinch
PRN | Corporate Officer/Principal | - | 22-08-21 |
Koen van Besien
PRN | Corporate Officer/Principal | - | 22-08-09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Redmond
BRD | Director/Board Member | 76 | 17-10-03 |
Marc Feldmann
CHM | Chairman | 79 | 18-04-08 |
Founder | 59 | 11-12-31 | |
Alexis Sandler
FOU | Founder | - | 11-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,341,815,988 | 1,197,879,870 ( 89.27 %) | 0 | 89.27 % |
Company contact information
HemoGenyx Pharmaceuticals Plc
60 Gracechurch Street 6th Floor
EC3V 0HR, London
+
http://www.hemogenyx.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-36.85% | 25.83M | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.74% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- SILF Stock
- Company Hemogenyx Pharmaceuticals Plc